Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1363 | 8244 | 36.0 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
1363 | 2 | TIRAPAZAMINE//DT DIAPHORASE//BIOREDUCTIVE DRUGS | 8244 |
2109 | 1 | CARBOGEN//TUMOR HYPOXIA//TUMOR OXYGENATION | 2354 |
7463 | 1 | NQO1//DT DIAPHORASE//EO9 | 1364 |
9841 | 1 | ETANIDAZOLE//HYPOXIC CELL SENSITIZER//HYPOXIC CELL RADIOSENSITIZER | 1115 |
12399 | 1 | KW 2149//MITOSENE//FR900482 | 908 |
14540 | 1 | ADEPT//NITROREDUCTASE//CB1954 | 764 |
14991 | 1 | MULTICELLULAR SPHEROIDS//MULTICELLULAR TUMOR SPHEROIDS//SPHEROID | 737 |
15678 | 1 | TIRAPAZAMINE//BIOREDUCTIVE DRUGS//SR 4233 | 698 |
28175 | 1 | CANC UK MRC//REPLICON INITIATION//HYPOXIA REOXYGENATION H R | 212 |
35768 | 1 | QUIESCENT CELL//BORON TRACEDRUG//MILD TEMPERATURE HYPERTHERMIA | 92 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TIRAPAZAMINE | authKW | 360816 | 1% | 86% | 113 |
2 | DT DIAPHORASE | authKW | 283371 | 2% | 58% | 133 |
3 | BIOREDUCTIVE DRUGS | authKW | 276609 | 1% | 84% | 89 |
4 | TUMOR HYPOXIA | authKW | 272880 | 2% | 50% | 147 |
5 | CARBOGEN | authKW | 246825 | 1% | 65% | 102 |
6 | NQO1 | authKW | 217802 | 2% | 40% | 148 |
7 | 2 NITROIMIDAZOLE | authKW | 170573 | 1% | 79% | 58 |
8 | CB1954 | authKW | 164020 | 1% | 92% | 48 |
9 | ADEPT | authKW | 154685 | 1% | 56% | 74 |
10 | NITROREDUCTASE | authKW | 153335 | 1% | 43% | 97 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 49354 | 40% | 0% | 3335 |
2 | Radiology, Nuclear Medicine & Medical Imaging | 30535 | 24% | 0% | 1995 |
3 | Chemistry, Medicinal | 3704 | 7% | 0% | 575 |
4 | Pharmacology & Pharmacy | 2113 | 12% | 0% | 971 |
5 | Biology | 1722 | 5% | 0% | 393 |
6 | Biophysics | 1112 | 5% | 0% | 437 |
7 | Chemistry, Organic | 831 | 6% | 0% | 512 |
8 | Biochemistry & Molecular Biology | 767 | 13% | 0% | 1045 |
9 | Toxicology | 404 | 3% | 0% | 239 |
10 | CYTOLOGY & HISTOLOGY | 283 | 0% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AUCKLAND CANC SOC | 81847 | 1% | 19% | 119 |
2 | EXPT CLIN ONCOL | 37804 | 1% | 14% | 72 |
3 | MED CHEM RADIOPHARM | 23631 | 0% | 30% | 21 |
4 | GRP RADIAT BIOL TUMOR PHYSIOL | 23478 | 0% | 32% | 20 |
5 | RADIAT ONCOL | 20658 | 7% | 1% | 616 |
6 | SIEMENS OXFORD MOL IMAGING | 19037 | 0% | 86% | 6 |
7 | MOL IMAGING EXPT RADIOTHER Y | 18422 | 0% | 29% | 17 |
8 | PARTICLE RADIAT ONCOL | 18251 | 0% | 25% | 20 |
9 | GRAY CANC TRUST | 16692 | 0% | 27% | 17 |
10 | MED BIOL PROD PROGRAM | 16486 | 0% | 64% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 89626 | 8% | 4% | 648 |
2 | BRITISH JOURNAL OF CANCER | 32479 | 5% | 2% | 399 |
3 | RADIOTHERAPY AND ONCOLOGY | 27169 | 3% | 4% | 210 |
4 | RADIATION RESEARCH | 19433 | 2% | 3% | 187 |
5 | CANCER CLINICAL TRIALS | 18036 | 0% | 20% | 25 |
6 | ANTI-CANCER DRUG DESIGN | 14669 | 1% | 8% | 50 |
7 | INTERNATIONAL JOURNAL OF RADIATION BIOLOGY | 11067 | 2% | 2% | 124 |
8 | CANCER RESEARCH | 9618 | 4% | 1% | 326 |
9 | BIOCHEMICAL PHARMACOLOGY | 8185 | 2% | 1% | 206 |
10 | ACTA ONCOLOGICA | 6676 | 1% | 2% | 88 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TIRAPAZAMINE | 360816 | 1% | 86% | 113 | Search TIRAPAZAMINE | Search TIRAPAZAMINE |
2 | DT DIAPHORASE | 283371 | 2% | 58% | 133 | Search DT+DIAPHORASE | Search DT+DIAPHORASE |
3 | BIOREDUCTIVE DRUGS | 276609 | 1% | 84% | 89 | Search BIOREDUCTIVE+DRUGS | Search BIOREDUCTIVE+DRUGS |
4 | TUMOR HYPOXIA | 272880 | 2% | 50% | 147 | Search TUMOR+HYPOXIA | Search TUMOR+HYPOXIA |
5 | CARBOGEN | 246825 | 1% | 65% | 102 | Search CARBOGEN | Search CARBOGEN |
6 | NQO1 | 217802 | 2% | 40% | 148 | Search NQO1 | Search NQO1 |
7 | 2 NITROIMIDAZOLE | 170573 | 1% | 79% | 58 | Search 2+NITROIMIDAZOLE | Search 2+NITROIMIDAZOLE |
8 | CB1954 | 164020 | 1% | 92% | 48 | Search CB1954 | Search CB1954 |
9 | ADEPT | 154685 | 1% | 56% | 74 | Search ADEPT | Search ADEPT |
10 | NITROREDUCTASE | 153335 | 1% | 43% | 97 | Search NITROREDUCTASE | Search NITROREDUCTASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BASS, PD , GUBLER, DA , JUDD, TC , WILLIAMS, RM , (2013) MITOMYCINOID ALKALOIDS: MECHANISM OF ACTION, BIOSYNTHESIS, TOTAL SYNTHESES, AND SYNTHETIC APPROACHES.CHEMICAL REVIEWS. VOL. 113. ISSUE 8. P. 6816-6863 | 184 | 72% | 33 |
2 | MEES, G , DIERCKX, R , VANGESTEL, C , VAN DE WIELE, C , (2009) MOLECULAR IMAGING OF HYPOXIA WITH RADIOLABELLED AGENTS.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 36. ISSUE 10. P. 1674-1686 | 125 | 96% | 103 |
3 | MEES, G , SATHEKGE, M , MAES, A , VAN DE WIELE, C , (2014) RADIOLABELLED PROBES TARGETING TUMOR HYPOXIA FOR PERSONALIZED MEDICINE.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 14. P. 2308-2318 | 130 | 96% | 2 |
4 | CHEN, Y , HU, LQ , (2009) DESIGN OF ANTICANCER PRODRUGS FOR REDUCTIVE ACTIVATION.MEDICINAL RESEARCH REVIEWS. VOL. 29. ISSUE 1. P. 29 -64 | 143 | 72% | 154 |
5 | WALSH, JC , LEBEDEV, A , ATEN, E , MADSEN, K , MARCIANO, L , KOLB, HC , (2014) THE CLINICAL IMPORTANCE OF ASSESSING TUMOR HYPOXIA: RELATIONSHIP OF TUMOR HYPOXIA TO PROGNOSIS AND THERAPEUTIC OPPORTUNITIES.ANTIOXIDANTS & REDOX SIGNALING. VOL. 21. ISSUE 10. P. 1516 -1554 | 172 | 61% | 20 |
6 | KELADA, OJ , CARLSON, DJ , (2014) MOLECULAR IMAGING OF TUMOR HYPOXIA WITH POSITRON EMISSION TOMOGRAPHY.RADIATION RESEARCH. VOL. 181. ISSUE 4. P. 335 -349 | 120 | 89% | 10 |
7 | PEETERS, SGJA , ZEGERS, CML , YAROMINA, A , VAN ELMPT, W , DUBOIS, L , LAMBIN, P , (2015) CURRENT PRECLINICAL AND CLINICAL APPLICATIONS OF HYPOXIA PET IMAGING USING 2-NITROIMIDAZOLES.QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 59. ISSUE 1. P. 39 -57 | 102 | 94% | 10 |
8 | LJUNGKVIST, ASE , BUSSINK, J , KAANDERS, JHAM , VAN DER KOGEL, AJ , (2007) DYNAMICS OF TUMOR HYPOXIA MEASURED WITH BIOREDUCTIVE HYPOXIC CELL MARKERS.RADIATION RESEARCH. VOL. 167. ISSUE 2. P. 127-145 | 151 | 77% | 77 |
9 | FLEMING, IN , MANAVAKI, R , BLOWER, PJ , WEST, C , WILLIAMS, KJ , HARRIS, AL , DOMARKAS, J , LORD, S , BALDRY, C , GILBERT, FJ , (2015) IMAGING TUMOUR HYPOXIA WITH POSITRON EMISSION TOMOGRAPHY.BRITISH JOURNAL OF CANCER. VOL. 112. ISSUE 2. P. 238 -250 | 84 | 97% | 21 |
10 | KROHN, KA , LINK, JM , MASON, RP , (2008) MOLECULAR IMAGING OF HYPOXIA.JOURNAL OF NUCLEAR MEDICINE. VOL. 49. ISSUE . P. 129S -148S | 133 | 69% | 179 |
Classes with closest relation at Level 2 |